Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018 05; 24(5):1079-1087.

View in: PubMed

subject areas

Adult
Aged
Allografts
Antigens, CD34
Chromosome Aberrations
Female
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Humans
Lymphocyte Depletion
Male
Middle Aged
Myelodysplastic Syndromes
Recurrence
Risk Assessment
Survival Analysis
Transplantation, Homologous
Treatment Outcome

authors with profiles

RICHARD E CHAMPLIN
BORJE S ANDERSSON
GABRIELA RONDON
UDAY R POPAT
BETUL ORAN
SAIRAH AHMED